Finland· FI-REL-REL52832
Ambrisentan Accord
A ambrisentan product containing ambrisentan, registered in Finland by Accord Healthcare B.V.. The same ATC class is registered in 18 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ambrisentan is registered in 18 of 19 countries.
Countries holding a registration under ATC C02KX02 (ambrisentan), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Ambrisentan · ATC C02KX02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ambrisentan costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ambrisentan · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$54.19
The record
At a glance
Fimea (Finland)- Active substance
- Ambrisentan
- Manufacturer
- Accord Healthcare B.V.
- Country
- Finland (FI)
- ATC code
- C02KX02
- ATC class
- Ambrisentan
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa53287330 x 1EUR 936.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
155 interactions on record for ambrisentan.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ambrisentan · interactions on record
155 records
- 5 severe
- 71 moderate
- 12 minor
- 67 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- CiclosporinL04AD01severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ambrisentan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMBRISENTAN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- United StatesambrisentanAurobindo Pharma Limited
- SpainAMBRISENTAN ACCORD 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- NetherlandsAmbrisentan Accord 5 mg, filmomhulde tablettenAccord Healthcare B.V.
- ItalyAMBRISENTAN ACCORDACCORD HEALTHCARE SLU
- FranceAMBRISENTAN ACCORD 5 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- SwedenAmbrisentan Accord 5 mg Filmdragerad tablettAccord Healthcare B.V.
- BelgiumAmbrisentan AB 5 mgAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Ambrisentan Accord, Ambrisentan Aop
- Belgium · Ambrisentan Accord, Ambrisentan Sandoz
- Bulgaria · Aмбрисентан Aкорд, Амбрисентан Зентива
- Cyprus · Ambrisentan Msn, Ambrisentan Sapiens
- Czechia · Ambrisentan Accord, Ambrisentan Sandoz
- Germany · Ambripuren, Ambrisentan
- Denmark · Ambrisentan "sandoz", Ambrisentan Accord
- Estonia · Ambrisentan Inteli, Ambrisentan Norameda
- Spain · Ambrisentan Accord, Ambrisentán Aurovitas
- France · Ambrisentan Accord, Ambrisentan Arrow
- United Kingdom (Northern Ireland) · Ambrisentan Accord, Ambrisentan Axunio
- Greece · Ambicipen, Ambrisentan Accord
- Croatia · Ambrisentan Accord
- Hungary · Ambrisentan Azr
- Ireland · Ambrisentan Accord
- Iceland · Ambrisentan Viatris, Volibris
- Italy · Ambrisentan Accord, Ambrisentan Medac
- Liechtenstein · Ambrisentan Viatris, Volibris
- Lithuania · Ambrisentan Aop, Ambrisentan Inteli
- Latvia · Ambrisentan Inteli, Ambrisentan Norameda
- Netherlands · Ambrisentan Accord, Ambrisentan Aop
- Norway · Ambrisentan Accord, Ambrisentan Viatris
- Portugal · Ambrisentano Accord, Ambrisentano Generis
- Sweden · Ambrisentan Accord, Ambrisentan Bluefish
- Slovenia · Ambrisentan Accord
- Slovakia · Ambrisentan Aop
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d60b91f5-2f33-4478-b94d-3d4a0ad16b16 GET /v1/drugs/d60b91f5-2f33-4478-b94d-3d4a0ad16b16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "7.5",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "5 mg",
"atc_label": "ambrisentaani",
"ma_number": "36085",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL52832",
"authorised_at": "2020-02-21"
}See everything about ambrisentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.